Cargando…
Clinical, Radiological, and Histopathological Characteristics of Periosteal Chondrosarcoma with a Focus on the Frequency of Medullary Invasion
Periosteal chondrosarcoma is an extremely rare malignant cartilage-forming tumour that originates from the periosteum and occurs on the surface of bone. Often, it is difficult to distinguish periosteal chondrosarcoma from other tumours, and reports in the literature are scarce. This study aims to in...
Autores principales: | Nakagawa, Makoto, Endo, Makoto, Susuki, Yosuke, Yokoyama, Nobuhiko, Maekawa, Akira, Nabeshima, Akira, Iida, Keiichiro, Fujiwara, Toshifumi, Setsu, Nokitaka, Matsunobu, Tomoya, Matsumoto, Yoshihiro, Yokoyama, Ryohei, Yamada, Yuichi, Kohashi, Kenichi, Yamamoto, Hidetaka, Oda, Yoshinao, Iwamoto, Yukihide, Nakashima, Yasuharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999951/ https://www.ncbi.nlm.nih.gov/pubmed/35407670 http://dx.doi.org/10.3390/jcm11072062 |
Ejemplares similares
-
Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line
por: Maekawa, Akira, et al.
Publicado: (2016) -
Risk Factors of Periprosthetic Infection in Patients with Tumor Prostheses Following Resection for Musculoskeletal Tumor of the Lower Limb
por: Fujiwara, Toshifumi, et al.
Publicado: (2020) -
Correction: Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor
por: Fukushima, Suguru, et al.
Publicado: (2018) -
Hypoxia-inducible factor 1 alpha is a poor prognostic factor and potential therapeutic target in malignant peripheral nerve sheath tumor
por: Fukushima, Suguru, et al.
Publicado: (2017) -
Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
por: Shimada, Eijiro, et al.
Publicado: (2021)